General Information of the Compound
| Compound ID |
CP0074631
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
6-methyl-4,5,6,7,8,13-hexahydrothieno[2,3-f][3]benzazecine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H19NS
|
||||||||||||||||||
| Molecular Weight |
257.402
|
||||||||||||||||||
| Canonical SMILES |
CN1CCc2sccc2Cc2ccccc2CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H19NS/c1-17-9-6-13-4-2-3-5-14(13)12-15-8-11-18-16(15)7-10-17/h2-5,8,11H,6-7,9-10,12H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
FHSMMEAYPKEOAQ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01195, D(1A) dopamine receptor
Protein ID: PT01169, D(1B) dopamine receptor
Protein ID: PT01005, D(2) dopamine receptor
Protein ID: PT01161, D(4) dopamine receptor